Lisinopril (Zestoretic, Zestril)
Lisinopril
Astrazeneca Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Astrazeneca Pharmaceuticals (Pty) Ltd
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Zestoretic 20 EACH TABLET CONTAINS HYDROCHLOROTHIAZIDE 12,5 mg LISINOPRIL DIHYDRATE EQUIVALENT TO LISINOPRIL ANHYDROUS 20 mg | 20 | 27036627/7.1.3/0366 | Registered | Not determined | None |
| Zestril 5 EACH TABLET CONTAINS LISINOPRIL 5,0 mg | 5Tablet | V0160V/7.1.3/160Approved 23 December 2021 | Registered | Not determined | PIPIL |
| Zestril 10 EACH TABLET CONTAINS LISINOPRIL 10,0 mg | 10Tablet | V0161V/7.1.3/161Approved 23 December 2021 | Registered | Not determined | PIPIL |
| Zestril 20 EACH TABLET CONTAINS LISINOPRIL 20,0 mg | 20Tablet | V0162V/7.1.3/162Approved 23 December 2021 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Hydrochlorothiazide
Consolidated Schedules 06 July 2026, line 3721
S3: Lisinopril
Consolidated Schedules 06 July 2026, line 3902
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2S)-1-[(2S)-6-Amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 5362119.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.